We treated 48 symptomatic osteochondral lesions of the talar dome arthroscopically. Of these, 18 patients had an osteochondral fracture with a loose fragment located in every case on the anteriolateral side of the talus. Treatment consisted of removal (16 cases) or fixation (2 cases) of the bone fragment. Thirty patients had chronic lesions (27 subchondral necrosis with a sequestrum and 3 extensive cysts). The lesion was posteromedial in 27 cases and the treatment consisted of removal of the sequestrum with curettage of the subchondral bone necrosis (27 cases) or transchondral drilling if the cartilage surface was intact (3 cases). All the patients were clinically and radiogically reviewed with a mean follow-up of 5 years (7 months to 11 years). Patients treated for an osteochondral fracture obtained significant better results (16 excellent or good results out of 18 cases) than those treated for chronic lesions (20 excellent or good results out of 30 cases). On radiographic examination, we noticed that, even at the longest follow-up, the bone healing was usually incomplete and the bone defect persisted indefinitely in case of extensive subchondral bone necrosis. The articular surface could be seen in 11 cases (8 computed arthrotomographies, 1 magnetic resonance imaging, and 2 second-look arthroscopies). The fibrous cartilaginous surface was apparently regular in 6 cases without any clear correlation with our clinical results. This study suggests that we must make a distinction between osteochondral fractures (recent or not healed) located in the anterolateral part of the talar dome, which carry a good prognosis, and necrotic lesions located medially, which are less likely to have a favorable outcome.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/ar.1999.v15.0150071 | DOI Listing |
J Shoulder Elbow Surg
January 2025
Lerner Children's Pavilion, Hospital for Special Surgery, New York, NY, USA. Electronic address:
Background: Humeral capitellar osteochondritis dissecans (OCD) lesions can be challenging to treat. Past studies have demonstrated grafting with extracellular matrix with bone marrow aspirate concentrate (ECM-BMAC) to be a viable technique for treatment of talar dome OCD, though little literature exists regarding application of this technique to the capitellum. This study aimed to report patient-reported outcomes (PROs) and return to sport (RTS) of pediatric patients at ≥1-year postoperatively who underwent ECM-BMAC grafting for capitellar OCD lesions.
View Article and Find Full Text PDFFoot Ankle Int
January 2025
Orthopaedic Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Arthrosc Tech
November 2024
Orthopaedic Department, Faculty of Medicine in Assiut, Al-Azhar University, Cairo, Egypt.
Osteochondral lesions of the talus are chondral lesions affecting the subchondral bone mostly due to acute ankle trauma, including either sprains or fractures. After failure of conservative treatment, operative treatment is necessary, with different surgical techniques described in the literature. We describe a single-step osteochondral autograft transfer to access the medial talar dome lesion that avoids the need for a medial malleolar osteotomy and therefore eliminates morbidity while reducing operative time.
View Article and Find Full Text PDFActa Radiol
November 2024
Radiology Department, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey.
Background: The etiology of medial-sided talar osteochondral lesions (OCLs) remains insufficiently understood.
Purpose: To identify anatomical risk factors contributing to the development of unilateral or bilateral OCL of the talus on the medial side, utilizing morphological parameters derived from magnetic resonance imaging (MRI).
Material And Methods: In this retrospective study, 24 ankle MRI scans from 12 patients exhibiting bilateral OCLs of the talar dome on the medial side, 24 ankle MRIs from 24 patients with unilateral medial-sided OCLs, and 24 healthy controls matched for age, sex, and side within each group were analyzed.
Am J Sports Med
December 2024
Linda and Mitch Hart Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, Vail, Colorado, USA.
Background: Microfracture is one surgical treatment strategy for osteochondral lesions of the talus (OLTs) but results in fibrocartilage repair tissue, which has inferior mechanical properties to native hyaline cartilage. Biological regulation of microfracture has been suggested to improve the quality of cartilage repair in patients.
Purpose: To determine if administration of losartan, fisetin, or losartan and fisetin combined can enhance microfracture-mediated cartilage repair of OLTs in a rabbit model.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!